drugset / Trial / NCT00216606
The Effectiveness and Safety of Topiramate on Prevention of Chronic Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of individualized doses (50 to 200 milligrams) of topiramate tablets compared against placebo for the prevention of chronic migraine headaches over a period of 16 weeks.
Timeline
- Start
- 2003-12
- Primary completion
- —
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topiramate | Small molecule | 50 mg | Oral |
| Subject | Topiramate | Small molecule | 200 mg | Oral |